Weak Fundamental Momentum Drags Dogwood Therapeutics Inc (DWTX) Lower

Dogwood Therapeutics Inc (NASDAQ:DWTX) has a beta value of 2.54 and has seen 8.09 million shares traded in the last trading session. The company, currently valued at $15.19M, closed the last trade at $11.40 per share which meant it lost -$1.95 on the day or -14.61% during that session. The DWTX stock price is -156.84% off its 52-week high price of $29.28 and 85.79% above the 52-week low of $1.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 13.68 million shares traded. The 3-month trading volume is 2.15 million shares.

Dogwood Therapeutics Inc (NASDAQ:DWTX) trade information

Sporting -14.61% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the DWTX stock price touched $11.40 or saw a rise of 61.07%. Year-to-date, Dogwood Therapeutics Inc shares have moved 357.83%, while the 5-day performance has seen it change 490.67%. Over the past 30 days, the shares of Dogwood Therapeutics Inc (NASDAQ:DWTX) have changed 387.18%. Short interest in the company has seen 13348.0 shares shorted with days to cover at 0.55.

Dogwood Therapeutics Inc (DWTX) estimates and forecasts

Figures show that Dogwood Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 97.75% over the past 6 months, with this year growth rate of 8.14%, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.02% over the past 5 years. Earnings growth for 2025 is a modest 13.86% while over the next 5 years, the company’s earnings are expected to increase by 5.11%.

DWTX Dividends

Dogwood Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 1.25% shares in the company for having 16.71 shares of worth $0.19 million while later fund manager owns 5.9 shares of worth $67294.0 as of Nov 30, 2024 , which makes it owner of about 0.44% of company’s outstanding stock.